Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35163
Title: Immunoglobulin G genetic variation can confound assessment of antibody levels via altered binding to detection reagents.
Austin Authors: Purcell, Ruth A;Aurelia, L Carissa;Esterbauer, Robyn;Allen, Lilith F;Bond, Katherine A;Williamson, Deborah A;Trevillyan, Janine M;Trubiano, Jason ;Juno, Jennifer J;Wheatley, Adam K;Davenport, Miles P;Nguyen, Thi Ho;Kedzierska, Katherine;Kent, Stephen J;Selva, Kevin John;Chung, Amy W
Affiliation: Department of Microbiology and Immunology The Peter Doherty Institute for Infection and Immunity, University of Melbourne Melbourne VIC Australia.
Department of Microbiology and Immunology The Peter Doherty Institute for Infection and Immunity, University of Melbourne Melbourne VIC Australia.
Victorian Infectious Diseases Reference Laboratory (VIDRL) The Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia.;Walter and Eliza Hall Institute of Medical Research Parkville VIC Australia.;Department of Infectious Diseases The Peter Doherty Institute for Infection and Immunity, University of Melbourne Melbourne VIC Australia.
Department of Infectious Diseases The Peter Doherty Institute for Infection and Immunity, University of Melbourne Melbourne VIC Australia.;Centre for Antibiotic Allergy and Research, Department of Infectious Diseases Austin Health Heidelberg VIC Australia.
Infectious Diseases
Department of Microbiology and Immunology The Peter Doherty Institute for Infection and Immunity, University of Melbourne Melbourne VIC Australia.
Kirby Institute University of New South Wales Kensington NSW Australia.
Issue Date: 2024
Date: 2024
Publication information: Clinical & Translational Immunology 2024; 13(3)
Abstract: Amino acid variations across more than 30 immunoglobulin (Ig) allotypes may introduce structural changes that influence recognition by anti-Ig detection reagents, consequently confounding interpretation of antibody responses, particularly in genetically diverse cohorts. Here, we assessed a panel of commercial monoclonal anti-IgG1 clones for capacity to universally recognise two dominant IgG1 haplotypes (G1m-1,3 and G1m1,17). Four commercial monoclonal anti-human IgG1 clones were assessed via ELISAs and multiplex bead-based assays for their ability to bind G1m-1,3 and G1m1,17 IgG1 variants. Detection antibodies were validated against monoclonal IgG1 allotype standards and tested for capacity to recognise antigen-specific plasma IgG1 from G1m-1,3 and G1m1,17 homozygous and heterozygous SARS-CoV-2 BNT162b2 vaccinated (n = 28) and COVID-19 convalescent (n = 44) individuals. An Fc-specific pan-IgG detection antibody corroborated differences between hinge- and Fc-specific anti-IgG1 responses. Hinge-specific anti-IgG1 clone 4E3 preferentially bound G1m1,17 compared to G1m-1,3 IgG1. Consequently, SARS-CoV-2 Spike-specific IgG1 levels detected in G1m1,17/G1m1,17 BNT162b2 vaccinees appeared 9- to 17-fold higher than in G1m-1,3/G1m-1,3 vaccinees. Fc-specific IgG1 and pan-IgG detection antibodies equivalently bound G1m-1,3 and G1m1,17 IgG1 variants, and detected comparable Spike-specific IgG1 levels between haplotypes. IgG1 responses against other human coronaviruses and influenza were similarly poorly detected by 4E3 anti-IgG1 in G1m-1,3/G1m-1,3 subjects. Anti-IgG1 clone 4E3 confounds assessment of antibody responses in clinical cohorts owing to bias towards detection of G1m1,17 IgG1 variants. Validation of anti-Ig clones should include evaluation of binding to relevant antibody variants, particularly as the role of immunogenetics upon humoral immunity is increasingly explored in diverse populations.
URI: https://ahro.austin.org.au/austinjspui/handle/1/35163
DOI: 10.1002/cti2.1494
ORCID: 0000-0001-6378-5114
0000-0002-7091-0048
0000-0002-9072-1017
0000-0002-9294-7693
0000-0001-6141-335X
0000-0002-8539-4891
0000-0003-0020-9704
Journal: Clinical & Translational Immunology
Start page: e1494
PubMed URL: 38433763
Type: Journal Article
Subjects: IgG
allotype
anti‐immunoglobulin
polymorphisms
reproducibility
serology
Appears in Collections:Journal articles

Show full item record

Page view(s)

42
checked on Oct 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.